My annual investment review for 2022. This year has been a rollercoaster for the stock market, here are the key takeaways from my portfolio.
Bank Blues: A Reminder to Chill And Not Be So Pessimistic
A reminder to everyone to chill... and look at things from a broader perspective. Be less pessimistic and a little bit more optimistic.
The Place Holdings (SGX:E27) – Poised to Have a Good 2023?
Looking at the recent developments in this company, I feel that The Place Holdings have a high chance to have a good 2023 and beat expectations.
Regis Corporation (NYSE:RGS) – Why I Remain Optimistic On Its Turnaround
Why I remain optimistic on Regis Corporation's ($RGS) successful turnaround through cost-cutting, and growth initiatives under new management.
Haw Par Group (SGX:H02) – A Simple Analysis II
I covered Haw Par Group back in 2019. Hence I think it is time to revisit this company which is trading at multi year lows.
The One Book You Must Read to Improve Your Decision-Making Skills
A valuable read for investors looking to improve their decision-making skills in the stock market.
Medpace Holdings Inc (NASDAQ:MEDP) – A High-Growth Investment Opportunity in the CRO Industry
Discover the potential of investing in Medpace Holdings Inc ($MEDP), a leading global CROin the healthcare industry.
Navigating the Bear Market: Dollar Cost Averaging vs. Lump Sum Investing
Navigating the stock market: comparing the pros and cons of dollar cost averaging and lump sum investing. Which is right strategy for you?
3 Books That Got Me Started in Value Investing
uniQure NV (NASDAQ:QURE) – A Prognosis
We study uniQure NV ($QURE), a biotechnology company focused on developing gene therapies for rare diseases.